purpose delayed cerebral necrosis dn significant risk brain tumor patients treated irradiation differentiating dn tumor progression important clinical question distinction reliably conventional imaging techniques undertook pilot study assess ability proton magnetic resonance spectroscopy 1h mrs differentiate prospectively dn tumor series children treated primary brain tumors irradiation methods materials children ages years clinical mr imaging mri changes suggested diagnosis dn brain tumor underwent localized 1h mrs prior planned biopsy resection confirmatory histological procedure prospective 1h mrs interpretations based comparison spectral peak patterns quantitative peak area values normalized spectra marked depression intracellular metabolite peaks choline creatine compounds hypothesized indicate dn choline easily visible creatine metabolite peaks labeled tumor subsequent histological studies identified brain lesion dn tumor results patient series included cases dn seven tumor cases based histology mrs criteria prospectively identified seven patients active tumor patients histologically proven dn correctly discriminant analysis suggested primary diagnostic information differentiating dn tumor lay normalized mrs peak areas choline creatine compounds conclusions magnetic resonance spectroscopy shows promising sensitivity selectivity differentiating dn brain tumor novel diagnostic index based peak areas choline creatine compounds provide simple discriminant differentiating dn recurrent residual primary brain tumors high dose high dose NUMBER NUMBER n acetyl median high recurrent residual progressive recurrent progressive recurrent recurrent residual recurrent residual recurrent progressive